curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page
Potential drug for THIS mosquito-borne disease: IIT Roorkee researchers discover – Elets digitalLEARNING

Potential drug for THIS mosquito-borne disease: IIT Roorkee researchers discover – Elets digitalLEARNING

by palligoelme@gmail.com | Mar 17, 2025 | Clinical Trials

​  Researchers at IIT Roorkee have discovered a possible solution for a mosquito-borne disease – Chikungunya.  Researchers at IIT Roorkee have discovered a possible solution for a mosquito-borne disease – Chikungunya. 

IIT Roorkee Secures Breakthrough in Chikungunya Research with Potential Drug Discovery

by palligoelme@gmail.com | Mar 17, 2025 | Clinical Trials

​ IIT Roorkee, India March 17th, 2025: Scientists at the Indian Institute of Technology (IIT) Roorkee have studied a new possibility for treating Chikungunya, a mosquito-borne viral disease that causes fever, joint pain, muscle pain, and rash. Their research indicates...
Informed consent training for clinical research trials: online delivery

Informed consent training for clinical research trials: online delivery

by palligoelme@gmail.com | Mar 17, 2025 | Clinical Trials

​  Abstract This article describes how the South supra-region of the NIHR Clinical Research Network …  Abstract This article describes how the South supra-region of the NIHR Clinical Research Network … 
Hemogenyx Pharmaceuticals PLC Announces Recruitment of Second Patient for Clinical Trials

Hemogenyx Pharmaceuticals PLC Announces Recruitment of Second Patient for Clinical Trials

by palligoelme@gmail.com | Mar 17, 2025 | Clinical Trials

​    
Post-polio immune therapy aces human trials

Post-polio immune therapy aces human trials

by palligoelme@gmail.com | Mar 16, 2025 | Clinical Trials

​  Recent human trials of a new one-year-long immune-based treatment for post-polio syndrome, which can strike polio survivors years after the initial infection and be very debilitating, have produced positive results.  Recent human trials of a new one-year-long...
Novel cancer therapy works for 73 per cent Indian patients in clinical trials: Why the Lancet report is significant

Novel cancer therapy works for 73 per cent Indian patients in clinical trials: Why the Lancet report is significant

by palligoelme@gmail.com | Mar 16, 2025 | Clinical Trials

​  This is the first clinical trial of CAR T-cell therapy from India to be published in journal  This is the first clinical trial of CAR T-cell therapy from India to be published in journal 
« Older Entries
Next Entries »

Recent Posts

  • Evaluation of Postoperative Pain After Using Resin-Based and Bioceramic Sealers in Mandibular Molars With Asymptomatic Apical Periodontitis
  • Impact of Eradication Therapy on Helicobacter Pylori Infection With Chronic Obstructive Pulmonary Disease:
  • Hydrodissection With Neuroprolotherapy Versus Open Release for Carpal Tunnel Syndrome
  • Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance
  • Myofascial Release and Dynamic Cupping in Children

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®